Cardinal Health (CAH) News Today

Cardinal Health, Inc. (NYSE: CAH): Recent coverage is generally supportive, with the board reaffirming a quarterly dividend and analysts maintaining or raising their price expectations. The main qualification is that JPMorgan’s rating remains neutral, suggesting its higher target implies only modest upside from the cited share price.

• Positive Sentiment: Cardinal Health approved a quarterly dividend of $0.5158 per share, payable January 15, 2027, to shareholders of record on January 4. The declaration provides continued income for shareholders, though the article does not offer a new outlook on dividend growth. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Bank of America Securities maintained a Buy rating on CAH, signaling continued analyst confidence. Bank of America Securities Remains a Buy on Cardinal Health
• Positive Sentiment: Zacks highlighted CAH’s momentum and growth characteristics, while a separate screen included the company among stocks with strong interest coverage and financial resilience. These are supportive assessments, not new company announcements. Zacks Cardinal Health Momentum Stock Article
• Neutral Sentiment: JPMorgan raised its price target from $260 to $286 but kept a Neutral rating. The higher target is constructive, while the unchanged rating and limited implied upside temper the signal. Cardinal Health Given New Price Target at JPMorgan
• Neutral Sentiment: Other coverage asks whether the dividend is safe and whether the company can repeat its past performance; the headlines alone do not provide new financial results or a clear change in outlook. Is Cardinal Health’s Dividend Safe? Can Cardinal Health Stock Repeat Its Last Five Years?